Funding Opportunities

UMCCTS Pilot Project Program (PPP) Award

The intent of the UMCCTS Pilot Project Program (PPP) funding is to speed-up the rate of progress to move a research project, clinical finding, or other discovery into a broader network of activities, while maximizing the breadth of interdisciplinary skills applied to the research question. We are particularly interested in proposals which feature a clinical scientist working with a basic scientist and proposals with an emphasis on community-based research.

The next PPP solicitation is pending and will be announced at a future date...

The most recent Funding Announcement can be downloaded here.

Current and Past Awardees

UMass Life Sciences Moment Fund (LSMF)

The UMass LSMF supports projects that are inter-campus in orientation and directed towards life sciences projects related to clinical and translational research. To support this mission, projects must include at least one investigator from the UMass Worcester Campus and a collaborator from at least one of the other UMass campuses.

The next LSMF solicitation is pending and will be announced at a future date...

The most recent Funding Announcement can be downloaded here

Steering Review Committee members

Current and Past Awardees

The Next Hundred Million Pilot Projects

The Next Hundred Million Pilot Projects (NHMPP)serves as a dedicated pool of funding to spur innovative collaborations between MassBiologics of UMMS and investigators across the UMass System with the goal of enhancing the translation of discoveries for clinical use. Projects must include at least one investigator from MassBiologics of UMMS and a faculty investigator from at least one UMass campus. 

The next NHMPP solicitation is pending and will be announced at a future date...

The most recent Funding Announcement can be downloaded here.

NHMPP Scientific Review Committee members

Current and Past Awardees

UMCCTS Clinical Research Scholar (K12) Award

Training of investigators who will make a career of innovative, hypothesis-driven clinical and translational research is a top priority of the UMCCTS. The Clinical Research Scholar (K12) Program has been developed to address this need. The training program will combine coursework, seminars, and mentored research.

The next Clinical Research Scholar (K12) solicitation is pending and will be announced at a future date...

UMCCTS Clinical Research Scholar (K12) Review Committee members

Current and Past Awardees

UMCCTS Community Engagement Pilot Programs

These awards focus on community engaged research, defined as “the process of working collaboratively with and through groups of people affiliated by geographic proximity, special interest, or similar situations to  address issues affecting well-being of those people”.

The next Community Engagement solicitation is pending and will be announced at a future date...

The most recent Funding Announcement can be downloaded here

Current and Past Awardees

UMCCTS Small Conference Grants (SCS)

This funding opportunity is designed to leverage the convening capacity of the UMCCTS to create new, multidisciplinary teams to address a pressing health need.

Applications (2 pages or less) are accepted on a rolling basis (no due date) to nathaniel.hafer@umassmed.edu. Investigators will be notified of award approximately 2-3 weeks post submission.

For complete information, eligibility, and application details, please click here. 

Pfizer's Center for Therapeutic Innovation (CTI) 2015

Request for Translational Proposals: Biotherapeutic and Small Molecule Targets

All researchers, clinicians, and post-docs whose work meets the criteria are invited to apply.For more information about submitting a proposal, please contact Venkat Reddy, Venkateshwar.Reddy@pfizer.com or Nate Hafer, Nathaniel.Hafer@umassmed.edu

Proposal Deadline: Friday, June 12, 2015 - Please submit your proposal to one of the contacts listed above.

CTI is an innovative Pfizer program that partners with leading academic medical centers and patient foundations nationwide to speed the translation of novel targets into potential therapeutics. CTI seeks to identify and partner novel targets with the goal of identifying new compounds and accelerate drug development from validated target to proof-of-mechanism in humans. A partnership with CTI may include collaborative use of Pfizer’s proprietary antibody drug delivery technologies and/or compound library, broad publishing rights and financial awards in the form of milestone and royalty payments for successful programs.

Complete details and instructions can be downloaded here.

The CTI Pre-Proposal template can be downloaded here.

UMCCTS and Voyager Therapeutics

Developmental Therapeutics Awards Special Pilot Project Program 2014

To All UMass Worcester Faculty:

The UMass Center for Clinical and Translational Science (UMCCTS), in collaboration with Voyager Therapeutics, is announcing a special round of Pilot Project Programs (PPPs) focused on understanding and optimizing recombinant adeno-associated viral (rAAV) vectors for therapeutic use.

Investigators are invited to submit proposals related to the following topics:

  • Targeted systemic dosing of rAAVs
  • Preexisting immunity to rAAV vectors
  • Effect of anti-capsid T cell responses on rAAV expression
  • Regulated expression of the transgene product

Proposals will be evaluated by a Scientific Review Committee made up of representatives from UMass and Voyager in a two-step process:

  1. A brief letter of intent (LOI) will be reviewed.
  2. Full proposals will be solicited after LOI review and selected for funding.

The next UMCCTS and Voyager Therapeutics solicitation is pending and will be announced at a future date...

The most recent funding announcement can be downloaded here.